SanaCurrents on PDUFA decision for Tarsus’ (TARS) drug to treat dry eye caused by mites
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Probability Sentiment SUMMARY Staying focused on an FDA approval paid off [...]
Tarsus shares up in pre-market trading after impressive Phase IIb/III results
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) said prior to the opening of the market on June 21 that its Saturn-1 Phase IIb/III [...]
Tarsus Pharmaceuticals, Inc. (TARS) Probability Sentiment
$TARS Probability Sentiment SUMMARY If you’ve ever experienced dry, itchy eyes, you likely attributed the [...]